M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.78 EUR -1.02% Market Closed
Market Cap: 108.1m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Wall Street
Price Targets

MAAT Price Targets Summary
Maat Pharma SA

Wall Street analysts forecast MAAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MAAT is 15.3 EUR with a low forecast of 13.94 EUR and a high forecast of 16.8 EUR.

Lowest
Price Target
13.94 EUR
79% Upside
Average
Price Target
15.3 EUR
97% Upside
Highest
Price Target
16.8 EUR
116% Upside
Maat Pharma SA Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
25% Upside
206650
EuBiologics Co Ltd
9% Downside
IMAB
I-Mab
550% Upside
DVYSR
Devyser Diagnostics AB
7% Upside
MRUS
Merus NV
76% Upside
KZR
Kezar Life Sciences Inc
240% Upside
688520
Sinocelltech Group Ltd
53% Upside
4882
Perseus Proteomics Inc
27% Upside

Revenue
Forecast

Revenue Estimate
Maat Pharma SA

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 116%.

N/A
Past Growth
116%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Maat Pharma SA

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAAT's stock price target?
Price Target
15.3 EUR

According to Wall Street analysts, the average 1-year price target for MAAT is 15.3 EUR with a low forecast of 13.94 EUR and a high forecast of 16.8 EUR.

What is Maat Pharma SA's Revenue forecast?
Projected CAGR
116%

The compound annual growth rate of Maat Pharma SA's revenue for the next 3 years is 116%.

Back to Top